Shares of Gland Pharma fell up to 6% to the day’s low of Rs 1,745 on BSE in Tuesday’s trade after entities related to ex-promoter Dr Ravi Penmetsa likely sold 5.5% equity in the company. Large block deals of nearly 91 lakh shares were reported today in which shares worth about Rs 1,600 crore changed … Read more
Shares of Gland Pharma on Tuesday rallied up to 20% to the day’s high of Rs 1,610 after the company reported better-than-expected June quarter earnings with revenue growing 41% year-on-year (YoY). Global brokerage firm Jefferies upgraded the stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1,065 earlier. Bernstein … Read more
Indian market snapped a 3-day losing streak and closed in the green on Friday. The S&P BSE Sensex rose nearly 300 points while Nifty50 closed above 18200 levels. Sectorally, buying was seen in IT, realty, banks, and autos while selling was visible in healthcare, consumer durables, and public sector stocks. Stocks that were in focus … Read more
Shares of fell as much as 24% to Rs 1,681 per share in the last three trading sessions on the BSE after the company reported a fall of 20.14% in consolidated net profit to Rs 241.24 crore due to lower sales and higher expenses. In the second quarter of FY22, the profit after tax (PAT) … Read more
New Delhi: Shares of dropped 15% during the trading session on Thursday, registering its biggest intra-day loss in more than two years of listing at the bourses following a disappointing Q2 performance. The drug maker, which announced its results for the September 2022 quarter, reported a 20% year-on-year (YoY) decline in consolidated net profit at … Read more